CN101991582A - Pharmaceutical application of formoterol/budesonide powder for inhalation - Google Patents
Pharmaceutical application of formoterol/budesonide powder for inhalation Download PDFInfo
- Publication number
- CN101991582A CN101991582A CN2009100133977A CN200910013397A CN101991582A CN 101991582 A CN101991582 A CN 101991582A CN 2009100133977 A CN2009100133977 A CN 2009100133977A CN 200910013397 A CN200910013397 A CN 200910013397A CN 101991582 A CN101991582 A CN 101991582A
- Authority
- CN
- China
- Prior art keywords
- medicine
- formoterol
- inhalation
- patients
- budesonide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a pharmaceutical application of formoterol/budesonide powder for inhalation, in particular to an application of the preparation of the medicine for preventing asthmatic attack. The medicine is taken through oral inhalation to achieve the aim of local delivery; and compared with the systemic administration, the dosage is small, the side effects are small and the effect is obvious. In a test, after fifty patients with asthma caused by allergic constitution inhale the medicine twice per day one month before the allergy season and take for two months, forty five patients do not suffer asthmatic attack in the allergy season and five patients have mild symptom of expectoration but do not have obvious symptoms of asthmatic attack. Therefore, the obvious effect rate is up to 90% and the effective rate is up to 100%.
Description
Technical field
The present invention relates to the medical applications of budesonide formoterol powder inhalant aspect the prevention of asthma outbreak
Background technology
The asthma that allergic constitution causes is normally seasonable, generally is the season at the beginning of spring and autumn late summer, and the patient to the medicated powder allergy of a certain plant in these two seasons, causes allergic rhinitis or asthma often, and symptom probably can continue about one month.
Budesonide formoterol powder inhalant has used for many years on the asthma in treatment, and effect is fine, and this inhalant contains formoterol and two kinds of compositions of budesonide, synergism is arranged aspect the increasing the weight of of asthma by different binding modes alleviating.The mechanism of action of two kinds of compositions is as follows respectively: budesonide: the budesonide that sucks recommended dose has the antiinflammatory action of glucocorticoid to lung, can alleviate symptoms of asthma, and resistance is slow, and sb.'s illness took a turn for the worse, and side effect is lacked than the general medication relatively.Formoterol is a selectivity beta-2-adrenoreceptor agonists, the patient that the reversibility airway obstruction is arranged is had the effect of diastole bronchial smooth muscle.The bronchiectatic activity onset is rapid, onset in 1-3 minute after suction, and single dose can be kept 12 hours.In clinical trial, add formoterol in the budesonide, can improve symptoms of asthma and pulmonary function, sb.'s illness took a turn for the worse in minimizing.But using this inhalant now all is to re-use this kind medicine to treat in asthma attack, and this has just caused certain damage to patient's lung, and that is just better if outbreak that a kind of medicine can prevention of asthma is arranged.
Summary of the invention
The technical problem to be solved in the present invention provides the application of the medicine of budesonide formoterol powder inhalant aspect the outbreak of preparation prevention of asthma.
In order to solve the problem that prior art exists, the technical solution used in the present invention is:
Budesonide formoterol powder inhalant is used for the medicine of the outbreak of Polyglucan asthma in preparation.
Advantage and effect that the present invention had are:
Medicine of the present invention is to suck the purpose that reaches topical by the oral cavity, compares with the whole body administration, and dose is little, and side effect is little, and effect is obvious.After the patient of 50 asthma that cause owing to allergic constitution uses, arrived previous month in irritated season, begin to suck medicine of the present invention, inhale twice every day, inhaled two months, have 45 patients all not have asthma attack in irritated season, there are 5 patients that the symptom of slight expectoration is arranged, but do not have tangible asthma attack sign, obvious effective rate reaches 90%, and effective percentage reaches 100%.
The specific embodiment
Budesonide formoterol powder inhalant can be used for the outbreak of Polyglucan asthma, its application process is: in the previous moon of irritated arrival in season, begin to suck budesonide formoterol powder inhalant, twice of every day, the Spring Festival, patient hypersensitive can inhale two months, patient hypersensitive can be drawn onto White Dew these solar term and can stop to inhale for autumn, so just can the Polyglucan asthma attack.
Claims (1)
1. the medical applications of budesonide formoterol powder inhalant is characterized in that the application aspect the medicine for preparing the prevention of asthma outbreak.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100133977A CN101991582A (en) | 2009-08-25 | 2009-08-25 | Pharmaceutical application of formoterol/budesonide powder for inhalation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100133977A CN101991582A (en) | 2009-08-25 | 2009-08-25 | Pharmaceutical application of formoterol/budesonide powder for inhalation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101991582A true CN101991582A (en) | 2011-03-30 |
Family
ID=43782660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100133977A Pending CN101991582A (en) | 2009-08-25 | 2009-08-25 | Pharmaceutical application of formoterol/budesonide powder for inhalation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101991582A (en) |
-
2009
- 2009-08-25 CN CN2009100133977A patent/CN101991582A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2779532C (en) | Synergistic antiviral composition and use thereof | |
| CN101590107A (en) | Rhinitis ointment | |
| CN102133319B (en) | Medicament for relieving asthma and cough and preparation method thereof | |
| WO2021198940A1 (en) | Composition for preventing or treating chronic or acute virus infection and/or sepsis in humans or animals | |
| CN101152252A (en) | Traditional Chinese medicine for treating chronic rhinitis | |
| CN106667974A (en) | Preparation method of terbutaline sulfate solution for inhalation | |
| CN101829154B (en) | Preparation method of medicine composition for preventing and treating asthma | |
| CN105412118B (en) | Treat dyspneic Western medicine compound of acute and chronic and preparation method thereof | |
| CN101991582A (en) | Pharmaceutical application of formoterol/budesonide powder for inhalation | |
| CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| EP3125876B1 (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
| CN103083404A (en) | Nasal cavity protective agent | |
| WO2015131655A1 (en) | Use of fsk in preventing and treating chronic obstructive pulmonary disease | |
| CN102872324B (en) | Traditional Chinese medicine atomized mixture for treating chest surgery postoperative respiratory distress syndrom | |
| CN109875986A (en) | Medical applications of the mast cell membrane stabilizer in terms of preventing dermatitis breaking-out | |
| CN105326789B (en) | Ambroxol albuterol solution agent | |
| CN104189076B (en) | A kind of Traditional Chinese medicine plaster for treating children's cold asthma and preparation method thereof | |
| CN102686232B (en) | Polysaccharide polymer from the seeds of the tamarind tree for use in treating dry cough | |
| CN109876142A (en) | The medical applications of β 2 receptor agonist | |
| JP2002030000A (en) | Fundamental treatment for common cold | |
| CN102284031B (en) | Medicine composition for treating bronchial diseases and emphysema | |
| CN102727614B (en) | Chinese-western medicine preparation for treating chronic obstructive pulmonary disease | |
| CN105326790B (en) | The preparation method of ambroxol albuterol solution agent | |
| CN105380925A (en) | Ambroxol-salbutamol control released granule | |
| CN115737772A (en) | Beneficial nasal cavity atomized liquid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110330 |